Velnor Pharmaceuticals Private Limited
About Velnor Pharmaceuticals Private Limited
Data last updated:
Velnor Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 22 November 2023.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U21002RJ2023PTC091263.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sumit Vijay and Khushbu Lalwani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jaipur, Rajasthan.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.89 Lakh. For the same year it recorded a net profit of ₹3,665 (net margin 0.2%) and EBITDA of ₹3,665 (EBITDA margin 0.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Velnor Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan.
- Registered AddressPlot No. 1874, Manohar Pura Kacchi Basti, Jaipur, Rajasthan, India – 302017
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Velnor Pharmaceuticals Private Limited
FY 2025 filings availableVelnor Pharmaceuticals Private Limited reported revenue of ₹22.89 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹3,665 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹3,665 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.2% | |
| Net Profit Margin | 0.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Velnor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Velnor Pharmaceuticals Private Limited
Velnor Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Vijay | Director | 22 Nov 2023 | 2 Years 11 Months | Current |
| Khushbu Lalwani | Director | 22 Nov 2023 | 2 Years 11 Months | Current |
| Rubina | Director | 22 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Velnor Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Airmed Pharmaceuticals (India) Private Limited | ₹23.09 Lakh (FY 2020) | -47.0% | Hyderabad, Telangana, India | |||
| Boldkingsvorld Pharmaceuticals Private Limited | ₹23.06 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Marriop Pharmaceuticals Private Limited | ₹23.01 Lakh (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Argor Pharmaceuticals Private Limited | ₹23 Lakh (FY 2024) | 73.0% | Chennai, Tamil Nadu, India | |||
| SVKC Pharmaceuticals Private Limited | ₹22.97 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Velnor Pharmaceuticals Private Limitedthis company | ₹22.89 Lakh (FY 2025) | ₹3,665 | 0.2% | Jaipur, Rajasthan, India | ||
| Fyzen Pharmaceuticals Private Limited | ₹22.85 Lakh (FY 2025) | 47.0% | Thane, Maharashtra, India | |||
| Dr.C Pharmaceuticals Private Limited | ₹22.84 Lakh (FY 2025) | 13.0% | Shilpa Enclave Madhapur Serilingampally, Telangana, India | |||
| Annpride Pharmaceuticals Private Limited | ₹22.83 Lakh (FY 2016) | New Delhi, Delhi, India | ||||
| Ragnia Pharmaceuticals Private Limited | ₹22.8 Lakh (FY 2024) | 248.0% | Lucknow, Uttar Pradesh, India | |||
| Symira Pharmaceuticals Private Limited | ₹22.78 Lakh (FY 2025) | -32.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Velnor Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Velnor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Velnor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Velnor Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Velnor Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Khushbu Lalwani was appointed as Director on 22 Nov 2023.
Frequently asked questions
Velnor Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in paper and paper products, within the paper industry. It was incorporated on 22 November 2023 (3+ years old) and is registered under CIN U21002RJ2023PTC091263.
Velnor Pharmaceuticals has 3 current directors:
- Sumit Vijay - Director
- Khushbu Lalwani - Director
- Rubina - Director
The latest financial statements of Velnor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Velnor Pharmaceuticals is U21002RJ2023PTC091263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Velnor Pharmaceuticals was incorporated on 22 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Velnor Pharmaceuticals by revenue are Airmed Pharmaceuticals (India) Private Limited, Boldkingsvorld Pharmaceuticals Private Limited, Marriop Pharmaceuticals Private Limited, Argor Pharmaceuticals Private Limited, SVKC Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Khushbu Lalwani was appointed as Director on 22 Nov 2023. Rubina was appointed as Director on 22 Nov 2023. Sumit Vijay was appointed as Director on 22 Nov 2023.
The registered office of Velnor Pharmaceuticals is at Plot No. 1874, Manohar Pura Kacchi Basti, Jaipur, Rajasthan, India – 302017.
Velnor Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
The compliance status of Velnor Pharmaceuticals is compliant as of 19 September 2026. The company is actively filing with the Registrar of Companies.
Velnor Pharmaceuticals can be reached at its registered office: Plot No. 1874, Manohar Pura Kacchi Basti, Jaipur, Rajasthan, India – 302017.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
